Publicaciones en colaboración con investigadores/as de Mizan Tepi University (22)

2019

  1. Erratum: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6))

    The Lancet

  2. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-Adjusted life-years for 29 cancer groups, 1990 to 2017: A systematic analysis for the global burden of disease study

    JAMA Oncology, Vol. 5, Núm. 12, pp. 1749-1768

  3. Past, present, and future of global health financing: a review of development assistance, government, out-of-pocket, and other private spending on health for 195 countries, 1995–2050

    The Lancet, Vol. 393, Núm. 10187, pp. 2233-2260

2018

  1. Alcohol use and burden for 195 countries and territories, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016

    The Lancet, Vol. 392, Núm. 10152, pp. 1015-1035

  2. Erratum: Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1736–1788)(S0140673618322037)(10.1016/S0140-6736(18)32203-7))

    The Lancet

  3. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017

    The Lancet, Vol. 392, Núm. 10159, pp. 1736-1788

  4. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016 a systematic analysis for the global burden of disease study global burden of disease cancer collaboration

    JAMA Oncology, Vol. 4, Núm. 11, pp. 1553-1568

  5. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017

    The Lancet, Vol. 392, Núm. 10159, pp. 1923-1994

  6. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017

    The Lancet, Vol. 392, Núm. 10159, pp. 1859-1922

  7. Global, regional, and national incidence, prevalence, and years lived with disability for 354 Diseases and Injuries for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017

    The Lancet, Vol. 392, Núm. 10159, pp. 1789-1858

  8. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: A systematic analysis from the Global Burden of Disease Study 2016

    The Lancet, Vol. 391, Núm. 10136, pp. 2236-2271

  9. Spending on health and HIV/AIDS: domestic health spending and development assistance in 188 countries, 1995–2015

    The Lancet, Vol. 391, Núm. 10132, pp. 1799-1829

  10. The burden of cardiovascular diseases among us states, 1990-2016

    JAMA Cardiology, Vol. 3, Núm. 5, pp. 375-389

2017

  1. Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015

    Journal of the American College of Cardiology, Vol. 70, Núm. 1, pp. 1-25

  2. Global, regional, and national age-sex specifc mortality for 264 causes of death, 1980-2016: A systematic analysis for the Global Burden of Disease Study 2016

    The Lancet, Vol. 390, Núm. 10100, pp. 1151-1210

  3. Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

    The Lancet Neurology, Vol. 16, Núm. 11, pp. 877-897

  4. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study Global Burden of Disease Cancer Collaboration

    JAMA Oncology, Vol. 3, Núm. 4, pp. 524-548

  5. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016

    The Lancet, Vol. 390, Núm. 10100, pp. 1345-1422

  6. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016

    The Lancet, Vol. 390, Núm. 10100, pp. 1260-1344

  7. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016

    The Lancet, Vol. 390, Núm. 10100, pp. 1211-1259